Alcobra Company Profile (NASDAQ:ADHD)

About Alcobra

Alcobra logoAlcobra Ltd is an Israel-based Biopharmaceutical company. It focuses on the development and commercialization of a proprietary drug, MG01CI, to treat Attention Deficit Hyperactivity Disorder (ADHD), a common and morbid neuropsychiatric condition in children and adults. Adult ADHD is associated with increased health risks and healthcare costs, higher divorce rates, lower levels of socioeconomic attainment, lower academic achievement, unemployment and work place deficits, increased risks for motor vehicle accidents, greater likelihood of additional psychiatric disorders, increased criminal activity and incarceration, and higher rates of substance use and abuse. MG01CI product has completed phase two studies.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ADHD
  • CUSIP:
Key Metrics:
  • Previous Close: $5.01
  • 50 Day Moving Average: $4.65
  • 200 Day Moving Average: $4.56
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -5.09
  • P/E Growth: 0.00
  • Market Cap: $146.08M
  • Outstanding Shares: 27,562,000
  • Beta: 1.24
Additional Links:
Companies Related to Alcobra:

Analyst Ratings

Consensus Ratings for Alcobra (NASDAQ:ADHD) (?)
Ratings Breakdown: 1 Hold Rating, 5 Buy Ratings
Consensus Rating:Buy (Score: 2.83)
Consensus Price Target: $12.40 (134.40% upside)

Analysts' Ratings History for Alcobra (NASDAQ:ADHD)
Show:
DateFirmActionRatingPrice TargetDetails
8/25/2016Jefferies GroupReiterated RatingBuyView Rating Details
8/1/2016Barclays PLCInitiated CoverageEqual Weight$8.00View Rating Details
6/21/2016Roth CapitalReiterated RatingBuy$12.00View Rating Details
6/7/2016Canaccord GenuityInitiated CoverageBuyView Rating Details
6/7/2016Cantor FitzgeraldInitiated CoverageBuy$16.00View Rating Details
1/25/2016Oppenheimer Holdings Inc.Initiated CoverageOutperform$16.00View Rating Details
8/9/2015WBB SecuritiesReiterated RatingHold$5.00View Rating Details
6/24/2015Piper Jaffray Cos.Set Price TargetBuy$21.00View Rating Details
11/17/2014AegisDowngradeBuy -> HoldView Rating Details
10/23/2014FBR & CoDowngradeOutperform -> Market Perform$22.00 -> $4.00View Rating Details
10/6/2014ING GroupReiterated RatingBuyView Rating Details
(Data available from 8/29/2014 forward)

Earnings

Earnings History for Alcobra (NASDAQ:ADHD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/30/2016Q216($0.22)N/AView Earnings Details
5/16/2016Q116($0.22)($0.18)ViewListenView Earnings Details
2/17/2016Q415($0.24)($0.20)ViewListenView Earnings Details
11/17/2015Q315($0.31)($0.20)ViewN/AView Earnings Details
8/13/2015Q215($0.30)($0.24)ViewListenView Earnings Details
5/6/2015($0.31)($0.26)ViewN/AView Earnings Details
2/12/2015Q4($0.57)($0.50)ViewN/AView Earnings Details
11/17/2014Q3 14($0.56)($0.77)ViewN/AView Earnings Details
8/11/2014Q2($0.57)($0.57)ViewListenView Earnings Details
5/15/2014Q114($0.57)ViewN/AView Earnings Details
2/13/2014Q413($0.35)($0.45)ViewN/AView Earnings Details
11/7/2013Q313($0.28)ViewN/AView Earnings Details
8/6/2013Q213($0.06)($0.15)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Alcobra (NASDAQ:ADHD)
Current Year EPS Consensus Estimate: $-0.97 EPS
Next Year EPS Consensus Estimate: $-1.04 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163($0.19)($0.15)($0.17)
Q2 20163($0.22)($0.20)($0.21)
Q3 20163($0.27)($0.22)($0.25)
Q4 20163($0.40)($0.28)($0.32)
Q1 20171($0.22)($0.22)($0.22)
Q2 20171($0.18)($0.18)($0.18)
Q3 20171($0.18)($0.18)($0.18)
Q4 20171($0.18)($0.18)($0.18)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Alcobra (NASDAQ:ADHD)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Alcobra (NASDAQ:ADHD)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Alcobra (NASDAQ:ADHD)
DateHeadline
investornewswire.com logoAlcobra Ltd. (NASDAQ:ADHD) Gets 0 Recommendations To Sell - Investor Newswire (NASDAQ:ADHD)
www.investornewswire.com - August 23 at 9:32 AM
News IconSell-side Price Target Review on Alcobra Ltd. (NASDAQ:ADHD) - Post News (NASDAQ:ADHD)
www.kentuckypostnews.com - August 22 at 8:05 AM
investornewswire.com logoWill Alcobra Ltd. (NASDAQ:ADHD) Hit $17 Price Target? - Investor Newswire (NASDAQ:ADHD)
www.investornewswire.com - August 16 at 3:19 PM
publicnow.com logoAlcobra Ltd. to Release Second Quarter Financial Results and Host Corporate Update Conference Call & Webcast on Tuesday, August 30 (NASDAQ:ADHD)
www.publicnow.com - August 15 at 10:33 AM
finance.yahoo.com logoIs a Surprise Coming for Alcobra (ADHD) This Earnings Season? (NASDAQ:ADHD)
finance.yahoo.com - August 9 at 12:03 PM
finance.yahoo.com logoWhat's in Store for Adverum (ADVM) this Earnings Season? (NASDAQ:ADHD)
finance.yahoo.com - August 8 at 3:19 PM
ftsenews.co.uk logoNew Broker Ratings For Alcobra Ltd. (ADHD) - FTSE News.co.uk - FTSE News (NASDAQ:ADHD)
www.ftsenews.co.uk - August 5 at 8:43 PM
finance.yahoo.com logoAlcobra (ADHD) Looks Good: Stock Adds 14.4% in Session (NASDAQ:ADHD)
finance.yahoo.com - August 4 at 11:49 AM
breakingfinancenews.com logoAlcobra Ltd (NASDAQ:ADHD) price target upped to $8 as recorded today by Barclays Capital (NASDAQ:ADHD)
breakingfinancenews.com - August 1 at 8:05 AM
investornewswire.com logoCan Shares Of Alcobra Ltd. (NASDAQ:ADHD) Hit $17? - Investor Newswire (NASDAQ:ADHD)
www.investornewswire.com - July 26 at 3:21 PM
News IconStock Displaying Signs of a Downtrend: Alcobra Ltd. (NASDAQ:ADHD) - Press Telegraph (NASDAQ:ADHD)
presstelegraph.com - July 23 at 3:18 PM
News IconWere Analysts Bullish Alcobra Ltd (NASDAQ:ADHD) This Week? - Consumer Eagle (NASDAQ:ADHD)
www.consumereagle.com - July 22 at 3:17 PM
globenewswire.com logoAlcobra Granted European Orphan Drug Designation for Metadoxine in Fragile X Syndrome (NASDAQ:ADHD)
globenewswire.com - July 19 at 8:45 PM
kcregister.com logoChina Metro-Rural Holdings Limited (NYSEMKT:CNR) plummeted -15.07% : Alcobra Ltd. (NASDAQ:ADHD ... - KC Register (NASDAQ:ADHD)
www.kcregister.com - July 19 at 3:18 PM
investornewswire.com logoIs $17 Price Target Attainable For Alcobra Ltd. (NASDAQ:ADHD)? - Investor Newswire (NASDAQ:ADHD)
www.investornewswire.com - July 19 at 9:30 AM
streetinsider.com logoAlcobra Ltd. (ADHD) Granted EC Orphan Drug Designation for Metadoxine in Fragile X Syndrome - StreetInsider.com (NASDAQ:ADHD)
www.streetinsider.com - July 19 at 9:30 AM
News IconAlcobra Limited Ord (NASDAQ:ADHD) Shorts Decreased by 3.56% After Short Covering - Consumer Eagle (NASDAQ:ADHD)
www.consumereagle.com - July 16 at 3:19 PM
ftsenews.co.uk logoNew Broker Ratings For Alcobra Ltd. (ADHD) - FTSE News (NASDAQ:ADHD)
www.ftsenews.co.uk - July 15 at 7:35 PM
investornewswire.com logoStrong Sell Calls For Alcobra Ltd. (NASDAQ:ADHD) At 0 - Investor Newswire (NASDAQ:ADHD)
www.investornewswire.com - July 12 at 9:20 AM
News IconAlcobra Limited Ord (NASDAQ:ADHD) Short Interest Decreased By 3.56% - Engelwood Daily (NASDAQ:ADHD)
www.engelwooddaily.com - July 10 at 3:18 PM
fiscalstandard.com logoNext Weeks Broker Price Targets For Alcobra Ltd. (ADHD) - Fiscal Standard (NASDAQ:ADHD)
www.fiscalstandard.com - July 10 at 8:03 AM
kcregister.com logoInvestors Watch List: Alcobra Ltd. (NASDAQ:ADHD), KeyCorp. (NYSE:KEY), Symantec Corporation (NASDAQ:SYMC ... - KC Register (NASDAQ:ADHD)
www.kcregister.com - July 8 at 3:20 PM
News IconHow Many Alcobra Ltd (NASDAQ:ADHD)'s Analysts Are Bullish? - Press Telegraph (NASDAQ:ADHD)
presstelegraph.com - July 7 at 3:19 PM
fiscalstandard.com logoBroker Outlook For Alcobra Ltd. (ADHD) - Fiscal Standard (NASDAQ:ADHD)
www.fiscalstandard.com - July 6 at 3:19 PM
globenewswire.com logoAlcobra Ltd. to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference - GlobeNewswire (press release) (NASDAQ:ADHD)
globenewswire.com - July 5 at 3:18 PM
finance.yahoo.com logoAlcobra Ltd. to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference (NASDAQ:ADHD)
finance.yahoo.com - July 5 at 8:00 AM
fiscalstandard.com logoBroker Outlook For The Week Ahead Alcobra Ltd. (ADHD) - Fiscal Standard (NASDAQ:ADHD)
www.fiscalstandard.com - July 4 at 8:05 AM
News IconAlcobra Limited Ord (NASDAQ:ADHD) Shorted Shares Decreased By 3.56% - Engelwood Daily (NASDAQ:ADHD)
www.engelwooddaily.com - June 29 at 3:16 PM
tradecalls.org logoRoth Capital Reinstates Alcobra Ltd to Buy - Trade Calls (NASDAQ:ADHD)
www.tradecalls.org - June 28 at 8:30 AM
investornewswire.com logoStrong Sell Calls Recommendations For Alcobra Ltd. (NASDAQ:ADHD) At 0 - Investor Newswire (NASDAQ:ADHD)
www.investornewswire.com - June 28 at 8:30 AM
fiscalstandard.com logoAlcobra Ltd. (ADHD) Broker Price Targets For The Coming Week - Fiscal Standard (NASDAQ:ADHD)
www.fiscalstandard.com - June 27 at 8:04 AM
ftsenews.co.uk logoAlcobra Ltd. (ADHD) Updated Price Targets - FTSE News (NASDAQ:ADHD)
www.ftsenews.co.uk - June 24 at 3:16 PM
news.cmlviz.com logoAlcobra Ltd. (NasdaqGM:ADHD) Stock Momentum Hits Weakness - CML News (NASDAQ:ADHD)
news.cmlviz.com - June 23 at 11:04 AM
investornewswire.com logoStrong Buy Calls Count For Alcobra Ltd. (NASDAQ:ADHD) At 4 - Investor Newswire (NASDAQ:ADHD)
www.investornewswire.com - June 21 at 8:05 AM
News IconAnalysts Offer Insights on Healthcare Companies: Alcobra Ltd (NASDAQ: ADHD), Atara Biotherapeutics Inc (NASDAQ ... - Analyst Ratings (NASDAQ:ADHD)
www.analystratings.com - June 8 at 9:24 PM
benzinga.com logoAlcobra Shares Initiated At Buy; Cantor Sees 'Greater Opportunity For Success' (NASDAQ:ADHD)
www.benzinga.com - June 7 at 11:42 AM
finance.yahoo.com logoCoverage initiated on Alcobra Pharma by Cantor Fitzgerald (NASDAQ:ADHD)
finance.yahoo.com - June 7 at 9:41 AM
capitalcube.com logoAlcobra Ltd. :ADHD-US: Earnings Analysis: Q1, 2016 By the Numbers : June 6, 2016 (NASDAQ:ADHD)
www.capitalcube.com - June 6 at 2:31 PM
News IconNext Weeks Broker Price Targets For Alcobra Ltd. (ADHD) - Share Trading News (NASDAQ:ADHD)
www.sharetrading.news - June 5 at 11:11 AM
News IconBuy, Sell Or Hold Rating For Alcobra Ltd. (ADHD)? - Share Trading News (NASDAQ:ADHD)
www.sharetrading.news - June 3 at 3:20 PM
globenewswire.com logoAlcobra Ltd. to Participate in Upcoming Investment Conferences - GlobeNewswire (press release) (NASDAQ:ADHD)
globenewswire.com - June 1 at 11:42 AM
publicnow.com logoAlcobra Ltd. to Participate in Upcoming Investment Conferences (NASDAQ:ADHD)
www.publicnow.com - June 1 at 8:23 AM
News IconWere Analysts Bearish Alcobra Ltd (NASDAQ:ADHD) This Week? - Wall Street Hints and News (NASDAQ:ADHD)
hintsnewsnetwork.com - May 25 at 6:43 PM
tradecalls.org logoRevenue Update on Alcobra Ltd(NASDAQ:ADHD) - Trade Calls (NASDAQ:ADHD)
www.tradecalls.org - May 22 at 11:26 AM
nasdaq.com logoAlcobra (ADHD) Catches Eye: Stock Adds 6.3% in Session - Nasdaq (NASDAQ:ADHD)
www.nasdaq.com - May 20 at 10:25 AM
finance.yahoo.com logoAlcobra (ADHD) Catches Eye: Stock Adds 6.3% in Session (NASDAQ:ADHD)
finance.yahoo.com - May 20 at 8:30 AM
thestreet.com logo7 Stocks Under $10 Making Big Moves Higher (NASDAQ:ADHD)
www.thestreet.com - May 20 at 6:08 AM
baystreet.ca logoAlcobra (ADHD) Gains With Losses on Horizon (NASDAQ:ADHD)
www.baystreet.ca - May 17 at 6:36 PM
News IconAfter Last Week What Do Analysts Think Of Alcobra Ltd. (ADHD) - Share Trading News (NASDAQ:ADHD)
www.sharetrading.news - May 16 at 6:30 PM
finance.yahoo.com logoEdited Transcript of ADHD earnings conference call or presentation 16-May-16 12:30pm GMT (NASDAQ:ADHD)
finance.yahoo.com - May 16 at 10:49 AM

Social

Alcobra (NASDAQ:ADHD) Chart for Monday, August, 29, 2016


Last Updated on 8/29/2016 by MarketBeat.com Staff